EGFR and lung adenocarcinoma: In this study, we identified the fusion gene VAPA-Rab31 in a patient with lung adenocarcinoma who did not harbor any known driver mutations in EGFR, KRAS, and ALK. Bronchial epithelial cells that overexpressed the fusion protein demonstrated enhanced proliferation and tumorigenicity.